|
Volumn 10, Issue 30, 2012, Pages 5791-5794
|
Conotoxin engineering: Dual pharmacophoric noradrenaline transport inhibitor/integrin binding peptide with improved stability
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVERSE EFFECT;
BINDING PEPTIDE;
CONOTOXINS;
CYCLIZED PEPTIDES;
INTEGRIN BINDING;
PEPTIDE SCAFFOLDS;
PHARMACOPHORES;
POTENTIAL VALUES;
RGD MOTIF;
TRANSPORT INHIBITORS;
GRAFTING (CHEMICAL);
PLASMA STABILITY;
SCAFFOLDS;
PEPTIDES;
ARGINYL-GLYCYL-ASPARTIC ACID;
ARGINYLGLYCYLASPARTIC ACID;
CONOTOXIN;
CYCLOPEPTIDE;
INTEGRIN;
NORADRENALIN;
NORADRENALIN TRANSPORTER;
OLIGOPEPTIDE;
ANIMAL;
ARTICLE;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
METABOLISM;
METHODOLOGY;
PROTEIN ENGINEERING;
PROTEIN STABILITY;
RAT;
TRANSPORT AT THE CELLULAR LEVEL;
ANIMALS;
BIOLOGICAL TRANSPORT;
CONOTOXINS;
HUMANS;
INTEGRINS;
MODELS, MOLECULAR;
NOREPINEPHRINE;
NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS;
OLIGOPEPTIDES;
PEPTIDES, CYCLIC;
PROTEIN ENGINEERING;
PROTEIN STABILITY;
RATS;
RATTUS;
|
EID: 84863962573
PISSN: 14770520
EISSN: None
Source Type: Journal
DOI: 10.1039/c2ob25133g Document Type: Article |
Times cited : (11)
|
References (24)
|